Lovaltech
PrivateLast Round
Seed
Apr 23, 2024
Total Funding Raised
$8.07M
Company Overview
Lovaltech is a biotechnology company that develops protein-based nasal vaccines designed to induce mucosal and systemic immunity to prevent infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lovaltech Comparables
Compare Lovaltech with similar companies based on industry and business-model similarity.
Lovaltech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 23, 2024 | ||||
| Grant | Apr 23, 2024 | ||||
| Pre Seed | Jun 1, 2023 |
Lovaltech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Da Vinci Labs | Seed, Pre Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 199% MoM, reaching 933.
- Feb 20, 2026
Grew 75% QoQ, from 4 to 7 employees.
Lovaltech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lovaltech's valuation, stock price, and market status.